Compared to cancer patients with the AA genotype, patients with the G allele (AG and GG genotypes) of rs7767396 have 56% and 57% reductions in median VEGF-A levels, in CALGB 80303 and CALGB 80203, respectively. The gene discussed is VEGFA; the disease is cancer.